Quest Diagnostics

By person

19 insiders · 34 transactions

23.7×

James E. Davis holds 23.7 times base salary in stock. $29.71M of shares against $1.25M in salary for 2025.

Salary from the company's own proxy. The shares are what James E. Davis last reported holding, valued at $242.72, the price Common Stock was last bought or sold at on the open market here, on 1 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Davis J. E.

CEO and President

—

$17.08M (6) scheduled

−$17.08M

122,423

0.1109%

$29.71M

−2.8%

PREVOZNIK MICHAEL E

SVP & General Counsel

—

$12.02M (10) scheduled

−$12.02M

42,337

0.0384%

$10.28M

−4.3%

Doherty Catherine T.

EVP, Regional Businesses

—

$6.96M (8) scheduled

−$6.96M

67,122

0.0608%

$16.29M

−1.9%

KUPPUSAMY KARTHIK

SVP, Clinical Solutions

—

$2.17M (2) scheduled

−$2.17M

13,557

0.0123%

$3.29M

+15.6%

Plewman Patrick

SVP for Diagnostic Services

—

$2.03M (4) scheduled

−$2.03M

15,293

0.0139%

$3.71M

−6.3%

DELANEY MARK E

SVP & Chief Commercial Officer

—

$1.86M (2) scheduled

−$1.86M

10,335

0.0094%

$2.51M

+105.9%

PFEIFFER GARY M

Director

—

$270.32K (1)

−$270.32K

31,005

0.0281%

$7.53M

+2.9%

Gregg Vicky B

Director

—

$239.70K (1)

−$239.70K

18,386

0.0167%

$4.46M

+2.3%

Deppe Michael J

SVP, Corp. Controller & CAO

—

35,196

0.0319%

$8.54M

+0.7%

SAMAD SAM

Executive Vice President & CFO

—

33,478

0.0303%

$8.13M

+91.7%

RING TIMOTHY M

Director

—

31,140

0.0282%

$7.56M

+8.1%

MAIN TIMOTHY L

Director

—

22,460

0.0203%

$5.45M

+11.8%

MORRISON DENISE M

Director

—

11,929

0.0108%

$2.90M

+24.5%

Lassiter Wright III

Director

—

10,323

0.0094%

$2.51M

+29.8%

Doi Tracey

Director

—

7,748

0.0070%

$1.88M

+43.4%

Diaz Luis

Director

—

5,196

0.0047%

$1.26M

+82.3%

GARDNER MARK A

SVP of Molecular Gen & Oncol

—

4,673

0.0042%

$1.13M

−2.5%

CARTER ROBERT B

Director

—

3,864

0.0035%

$937.87K

+160.7%

WENTWORTH TIMOTHY C

Director

—

1,358

0.0012%

$329.61K

+135,700%

Individual transactions

Insider

Date

Role

Action

Price

Amount

PREVOZNIK MICHAEL E

28 Aug 2026

SVP & General Counsel

Sold after exercise

430

$244.51

$105.14K

PREVOZNIK MICHAEL E

28 Aug 2026

SVP & General Counsel

Sold after exercise

6,237

$243.63

$1.52M

PREVOZNIK MICHAEL E

28 Aug 2026

SVP & General Counsel

Sold after exercise

16,010

$242.88

$3.89M

KUPPUSAMY KARTHIK

4 Jun 2026

SVP, Clinical Solutions

Sold after exercise

8,147

$200.00

$1.63M

Doherty Catherine T.

13 Feb 2026

EVP, Regional Businesses

Sold after exercise

351

$209.10

$73.39K

Doherty Catherine T.

13 Feb 2026

EVP, Regional Businesses

Sold after exercise

1,619

$208.21

$337.09K

Doherty Catherine T.

13 Feb 2026

EVP, Regional Businesses

Sold after exercise

3,500

$207.08

$724.79K

Doherty Catherine T.

13 Feb 2026

EVP, Regional Businesses

Sold after exercise

10,122

$206.37

$2.09M

Doherty Catherine T.

13 Feb 2026

EVP, Regional Businesses

Sold after exercise

10,573

$205.21

$2.17M

Plewman Patrick

10 Feb 2026

SVP for Diagnostic Services

Sold after exercise

5,662

$204.00

$1.16M

Davis J. E.

25 Nov 2025

CEO and President

Sold after exercise

4,747

$192.97

$916.04K

Davis J. E.

25 Nov 2025

CEO and President

Sold after exercise

41,004

$192.27

$7.88M

Davis J. E.

25 Nov 2025

CEO and President

Sold after exercise

9,342

$191.59

$1.79M

DELANEY MARK E

18 Nov 2025

SVP & Chief Commercial Officer

Sold after exercise

7,946

$187.35

$1.49M

PREVOZNIK MICHAEL E

26 Sep 2025

SVP & General Counsel

Sold after exercise

144

$188.66

$27.17K

PREVOZNIK MICHAEL E

26 Sep 2025

SVP & General Counsel

Sold after exercise

$187.22

$15.54K

PREVOZNIK MICHAEL E

24 Sep 2025

SVP & General Counsel

Sold after exercise

175

$187.02

$32.73K

PREVOZNIK MICHAEL E

23 Sep 2025

SVP & General Counsel

Sold after exercise

28,288

$187.12

$5.29M

Show all 34 transactions →

By person

Individual transactions

What was left out